Pharma and healthcare mutual funds have yielded impressive returns in 2024. The sector benefited from resilience amidst corrections in other sectors and steady growth in the domestic market. Experts suggest a cautious approach to investment due to current valuations. A phased allocation strategy of 10-15% is recommended, with potential for increasing allocation over time.
SEBI gives power to executive directors, whole-time members on reduction, waiver of interest for unpaid penalty
SEBI has empowered panels of Executive Directors and Whole-time Members to waive or reduce interest in recovery cases under specific conditions. This excludes cases involving
January 10, 2025